Cultured cells are used extensively in research, manufacturing, and for therapeutic purposes. Unfortunately, a large number of cell lines are mislabeled, contaminated, and misidentified, leading to results that are non-replicable, data that is erroneous, and conclusions that are faulty. These problems have often gone unnoticed and unchecked, costing labs a significant amount of time, money, and labor. The authentication of cell lines is a crucial quality-control step, and this webinar’s experts will elaborate on some of the recent efforts underway to eradicate these problems.
Dr. John Masters, Professor of Experimental Pathology, University College London; Director, Prostate Cancer Research Centre
Dr. Glyn Stacey, Head, Division of Cell Biology and Imaging; Director, UK Stem Cell Bank, National Institute for Biological Standards and Control Cancer Research Centre
Dr. Amanda Capes-Davis, Founding Manager and Honorary Scientist, CellBank Australia; Chair, International Cell Line Authentication Committee (ICLAC)